×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Rocket Pharmaceuticals Inc. (RCKT) NASDAQ

$20.85 0.17 (0.82%)

Market Cap: $1.89B

As of 06/20/24 04:00 PM EDT. Market closed.

(RCKT)

Rocket Pharmaceuticals Inc. (RCKT)
NASDAQ

$20.85
0.17 (0.82%)

Market Cap: $1.89B

As of 06/20/24 04:00 PM EDT. Market closed.

Add to Portfolio

rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Gaurav Shah
Full Time Employees
205
URL
Address
350 5th Ave Ste 7530, New York, New York, 10118-7501.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Gaurav Shah
Full Time Employees
205
CEO Compensation (Base)
$413,735
Address
350 5th Ave Ste 7530, New York, New York, 10118-7501.
PRICE CHART FOR ROCKET PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$20.68
Days Range
$20.31 - $21.02
52 week range
$14.89 - $32.53
Volume
0
Avg. Volume (30 days)
695,964
Market Cap
$1.89B
Dividend Yield
-
P/E
-
Shares Outstanding
90,782,211
Open
-
Previous Close
$20.68
Days Range
$20.31 - $21.02
52 week range
$14.89 - $32.53
Volume
0
Avg. Volume (30 days)
695,964
Market Cap
$1.89B
Dividend Yield
-
P/E
-
Shares Outstanding
90,782,211
FINANCIAL STATEMENTS FOR ROCKET PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ROCKET PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Makker GothamDirectorMar 21, 2024 Sale$28.43274,0007,790,943365,912Jun 10, 2024, 10:34 AM
Militello JohnSee RemarksMay 16, 2024 Sale$23.351,07925,19553,327May 20, 2024, 04:36 PM
Shah GauravCEOMay 16, 2024 Sale$23.359,790228,597728,069May 20, 2024, 04:33 PM
Wilson MartinGeneral CounselMay 16, 2024 Sale$23.351,04824,47165,762May 20, 2024, 04:29 PM
Patel KinnariSee RemarksMay 16, 2024 Sale$23.354,04694,474400,972May 20, 2024, 04:26 PM
Militello JohnSee RemarksApr 22, 2024 Sale$22.8783319,05154,406Apr 24, 2024, 04:06 PM
SOUTHWELL DAVID PDirectorApr 15, 2024 Option Exercise$4.3429,624128,627124,784Apr 16, 2024, 05:45 PM
SOUTHWELL DAVID PDirectorApr 12, 2024 Option Exercise$4.3470,000303,940165,160Apr 16, 2024, 05:45 PM
SOUTHWELL DAVID PDirectorApr 12, 2024 Sale$24.3670,0001,705,265105,444Apr 16, 2024, 05:45 PM
SOUTHWELL DAVID PDirectorApr 15, 2024 Sale$24.0510,000240,520114,784Apr 16, 2024, 05:45 PM
White Mark AndrewSee RemarksApr 08, 2024 Sale$24.6412,532308,76375,226Apr 10, 2024, 08:39 PM
Makker GothamDirectorMar 21, 2024 Sale$28.43274,0007,790,943365,912Mar 25, 2024, 08:58 PM
Militello JohnSee RemarksMar 21, 2024 Sale$28.102,49069,97955,239Mar 25, 2024, 08:54 PM
Militello JohnSee RemarksFeb 29, 2024 Option Exercise$12.5510,000125,50031,517Mar 04, 2024, 06:54 PM
Militello JohnSee RemarksFeb 29, 2024 Sale$29.8410,000298,45021,517Mar 04, 2024, 06:54 PM
Wilson MartinGeneral CounselFeb 29, 2024 Sale$29.334,100120,25718,680Mar 04, 2024, 06:48 PM
Wilson MartinGeneral CounselFeb 16, 2024 Sale$29.843,576106,7016,136Feb 21, 2024, 08:54 PM
Patel KinnariSee RemarksFeb 16, 2024 Sale$29.847,132212,805238,346Feb 21, 2024, 08:54 PM
Militello JohnSee RemarksFeb 16, 2024 Sale$29.843,23896,61513,195Feb 21, 2024, 08:54 PM
Shah GauravCEOFeb 16, 2024 Sale$29.8420,272604,876554,762Feb 21, 2024, 08:54 PM
Militello JohnSee RemarksJan 22, 2024 Sale$27.2063817,35610,159Jan 23, 2024, 04:22 PM
Makker GothamDirectorNov 15, 2023 Sale$22.5320,000450,6461,296,497Nov 16, 2023, 07:24 PM
Militello JohnSee RemarksOct 20, 2023 Sale$17.065649,6238,760Oct 25, 2023, 09:38 AM
Militello JohnSee RemarksFeb 17, 2023 Sale$19.061,07620,5091,782Oct 20, 2023, 06:37 PM
Makker GothamDirectorSep 29, 2023 Sale$21.144,67798,8641,316,497Oct 02, 2023, 09:02 PM
Makker GothamDirectorSep 28, 2023 Sale$21.0310,312216,8801,321,174Oct 02, 2023, 09:02 PM
RTW INVESTMENTS, LPDirectorAug 28, 2023 Option Exercise$18.962,000,00037,919,99918,657,605Aug 30, 2023, 04:15 PM
Patel KinnariSee RemarksAug 17, 2023 Sale$15.471,53423,733216,448Aug 21, 2023, 04:05 PM
Shah GauravCEOAug 17, 2023 Sale$15.474,76773,750524,854Aug 21, 2023, 04:05 PM
Militello JohnSee RemarksAug 17, 2023 Sale$15.472844,3945,570Aug 21, 2023, 04:05 PM
Militello JohnSee RemarksJul 20, 2023 Sale$19.0357310,9067,129Jul 24, 2023, 04:05 PM
Shah GauravCEOMay 17, 2023 Sale$21.384,12288,108521,642May 19, 2023, 04:05 PM
Patel KinnariSee RemarksMay 17, 2023 Sale$21.381,33028,429213,993May 19, 2023, 04:05 PM
Militello JohnSee RemarksMay 17, 2023 Sale$21.382455,2376,116May 19, 2023, 04:05 PM
Militello JohnSee RemarksApr 21, 2023 Sale$18.652,34243,6785,636Apr 25, 2023, 06:33 PM
Schwartz Jonathan DavidSee RemarksFeb 17, 2023 Sale$19.063,55767,79694,546Feb 22, 2023, 07:28 PM
Militello JohnSee RemarksFeb 17, 2023 Sale$19.061,24423,7111,614Feb 22, 2023, 07:28 PM
Shah GauravCEOFeb 17, 2023 Sale$19.0612,194232,418536,885Feb 22, 2023, 07:27 PM
RTW INVESTMENTS, LPDirectorOct 06, 2022 Buy$14.751,355,93219,999,99717,628,567Oct 11, 2022, 04:31 PM
Schwartz Jonathan DavidSee RemarksMar 31, 2022 Sale$16.1045,000724,499170,527Apr 04, 2022, 07:37 AM
Schwartz Jonathan DavidSee RemarksMar 30, 2022 Sale$16.4145,000738,652213,967Apr 04, 2022, 07:37 AM
Schwartz Jonathan DavidSee RemarksApr 01, 2022 Sale$16.1045,000724,589121,555Apr 04, 2022, 07:37 AM
Schwartz Jonathan DavidSee RemarksMar 30, 2022 Sale$16.4145,000738,652213,967Apr 01, 2022, 04:51 PM
Shah GauravCEOFeb 07, 2022 Buy$17.3422,000381,513517,639Feb 08, 2022, 04:43 PM
WONG RODERICKDirectorAug 27, 2021 Option Exercise$32.48812,51626,390,51916,272,635Aug 31, 2021, 07:11 PM
RTW INVESTMENTS, LPDirectorMay 11, 2021 Sale$40.03725,00029,023,48915,460,119May 13, 2021, 07:49 PM
Shah GauravCEOApr 01, 2021 Option Exercise$46.3722,2661,032,554511,986Apr 01, 2021, 09:09 PM
Shah GauravCEOMar 31, 2021 Option Exercise$45.947,493344,235517,905Apr 01, 2021, 09:09 PM
Shah GauravCEOMar 31, 2021 Option Exercise$44.5187,3533,887,647609,751Apr 01, 2021, 09:08 PM
Shah GauravCEOMar 30, 2021 Option Exercise$43.3285,8883,720,492614,092Apr 01, 2021, 09:08 PM
Shah GauravCEOMar 31, 2021 Option Exercise$1.6975,880128,237612,751Apr 01, 2021, 09:08 PM
Patel KinnariChief Operating OfficerMar 24, 2021 Option Exercise$1.4093,962131,979188,939Mar 26, 2021, 06:17 PM
Schwartz Jonathan DavidChief Medical OfficerFeb 01, 2021 Option Exercise$1.23224,529277,166224,529Feb 03, 2021, 09:06 PM
Patel KinnariChief Operating OfficerDec 28, 2020 Sale$56.7216,761950,745100,404Dec 30, 2020, 04:50 PM
RTW INVESTMENTS, LPDirectorDec 10, 2020 Buy$56.00247,72013,872,32017,530,044Dec 14, 2020, 07:19 PM
Shah GauravPresident & CEOMar 24, 2020 Option Exercise$13.7832,645449,8481,028,997Mar 26, 2020, 07:48 PM
Shah GauravPresident & CEOMar 24, 2020 Option Exercise$0.4390,92539,0981,061,642Mar 26, 2020, 07:48 PM
Patel KinnariChief Operating OfficerMar 18, 2020 Buy$9.501,0009,5006,675Mar 19, 2020, 07:56 PM
Shah GauravPresident & CEOFeb 25, 2020 Option Exercise$20.156,233125,595970,717Feb 27, 2020, 05:36 PM
Shah GauravPresident & CEOFeb 25, 2020 Option Exercise$0.43290,000125,628976,950Feb 27, 2020, 05:36 PM
RTW INVESTMENTS, LPDirectorDec 10, 2019 Buy$22.25225,0005,006,25017,282,324Dec 12, 2019, 03:43 PM
RTW INVESTMENTS, LPDirectorApr 16, 2019 Buy$17.50550,0059,625,08817,057,324Apr 18, 2019, 04:14 PM
Shah GauravSee RemarksMar 05, 2019 Sale$16.9025,000422,500686,950Mar 05, 2019, 07:23 PM
Shah GauravSee RemarksMar 04, 2019 Sale$17.2824,900430,272711,950Mar 05, 2019, 07:23 PM
Shah GauravSee RemarksMar 01, 2019 Sale$17.3425,000433,500736,850Mar 05, 2019, 07:23 PM
WONG RODERICKDirectorDec 28, 2018 Option Exercise$13.93100,0001,393,00016,507,319Dec 28, 2018, 05:43 PM
Patel KinnariChief Operating OfficerDec 20, 2018 Option Exercise$1.2155,86967,60155,869Dec 21, 2018, 05:00 PM
SOUTHWELL DAVID PDirectorDec 13, 2018 Sale$15.1938,768588,88695,160Dec 14, 2018, 09:06 PM
SOUTHWELL DAVID PDirectorDec 07, 2018 Sale$14.914,92373,402133,928Dec 10, 2018, 05:03 PM
SOUTHWELL DAVID PDirectorDec 06, 2018 Sale$15.1552,809800,056138,851Dec 10, 2018, 05:03 PM
Patel KinnariChief Operating OfficerDec 06, 2018 Buy$14.985,67585,0115,675Dec 10, 2018, 05:01 PM
WONG RODERICKDirectorNov 27, 2018 Option Exercise$15.50967,74215,000,00116,407,319Nov 29, 2018, 06:02 PM
Yalamanchi NaveenDirectorAug 01, 2018 Sale$22.0063714,014113,641Aug 03, 2018, 07:03 PM
SOUTHWELL DAVID PPresident and CEOJan 06, 2017 Buy$1.7560,000105,00062,765Jan 09, 2017, 05:54 PM
CARROLL J MARTINDirectorMay 13, 2016 Buy$9.0310,00090,29410,000May 17, 2016, 06:50 PM
Devon Park Associates, L.P.10% OwnerJul 14, 2015 Option Exercise$4.349,85742,7993,253,566Jul 16, 2015, 08:46 PM
Pitango Venture Capital Principals Fund IV, L.P.10% OwnerFeb 23, 2015 Buy$6.00212,3751,274,2501,292,584Feb 25, 2015, 08:36 PM
KARABELAS ARGERIS NDirectorFeb 23, 2015 Buy$6.00603,8323,622,9922,277,139Feb 25, 2015, 06:19 PM
CARE CAPITAL II LLC10% OwnerFeb 23, 2015 Buy$6.00603,8323,622,9922,277,139Feb 25, 2015, 06:16 PM
RHO VENTURES IV QP LP10% OwnerFeb 23, 2015 Buy$6.00958,2265,749,3562,870,584Feb 25, 2015, 06:15 PM
Kantesaria Devang10% OwnerFeb 23, 2015 Buy$6.00814,1664,884,9963,243,709Feb 25, 2015, 06:12 PM
DEVON PARK BIOVENTURES LP10% OwnerFeb 23, 2015 Buy$6.00814,1664,884,9963,243,709Feb 25, 2015, 06:11 PM
MedImmune Ventures, Inc.10% OwnerFeb 23, 2015 Buy$6.00416,6672,500,0021,917,906Feb 25, 2015, 06:10 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Makker GothamDirector03/21/20247,790,943
Militello JohnSee Remarks05/16/202425,195
Shah GauravCEO05/16/2024228,597
Wilson MartinGeneral Counsel05/16/202424,471
Patel KinnariSee Remarks05/16/202494,474
Militello JohnSee Remarks04/22/202419,051
SOUTHWELL DAVID PDirector04/15/2024128,627
SOUTHWELL DAVID PDirector04/12/2024303,940
SOUTHWELL DAVID PDirector04/12/20241,705,265
SOUTHWELL DAVID PDirector04/15/2024240,520
White Mark AndrewSee Remarks04/08/2024308,763
Makker GothamDirector03/21/20247,790,943
Militello JohnSee Remarks03/21/202469,979
Militello JohnSee Remarks02/29/2024125,500
Militello JohnSee Remarks02/29/2024298,450
Wilson MartinGeneral Counsel02/29/2024120,257
Wilson MartinGeneral Counsel02/16/2024106,701
Patel KinnariSee Remarks02/16/2024212,805
Militello JohnSee Remarks02/16/202496,615
Shah GauravCEO02/16/2024604,876
Militello JohnSee Remarks01/22/202417,356
Makker GothamDirector11/15/2023450,646
Militello JohnSee Remarks10/20/20239,623
Militello JohnSee Remarks02/17/202320,509
Makker GothamDirector09/29/202398,864
Makker GothamDirector09/28/2023216,880
RTW INVESTMENTS, LPDirector08/28/202337,919,999
Patel KinnariSee Remarks08/17/202323,733
Shah GauravCEO08/17/202373,750
Militello JohnSee Remarks08/17/20234,394
Militello JohnSee Remarks07/20/202310,906
Shah GauravCEO05/17/202388,108
Patel KinnariSee Remarks05/17/202328,429
Militello JohnSee Remarks05/17/20235,237
Militello JohnSee Remarks04/21/202343,678
Schwartz Jonathan DavidSee Remarks02/17/202367,796
Militello JohnSee Remarks02/17/202323,711
Shah GauravCEO02/17/2023232,418
RTW INVESTMENTS, LPDirector10/06/202219,999,997
Schwartz Jonathan DavidSee Remarks03/31/2022724,499
Schwartz Jonathan DavidSee Remarks03/30/2022738,652
Schwartz Jonathan DavidSee Remarks04/01/2022724,589
Schwartz Jonathan DavidSee Remarks03/30/2022738,652
Shah GauravCEO02/07/2022381,513
WONG RODERICKDirector08/27/202126,390,519
RTW INVESTMENTS, LPDirector05/11/202129,023,489
Shah GauravCEO04/01/20211,032,554
Shah GauravCEO03/31/2021344,235
Shah GauravCEO03/31/20213,887,647
Shah GauravCEO03/30/20213,720,492
Shah GauravCEO03/31/2021128,237
Patel KinnariChief Operating Officer03/24/2021131,979
Schwartz Jonathan DavidChief Medical Officer02/01/2021277,166
Patel KinnariChief Operating Officer12/28/2020950,745
RTW INVESTMENTS, LPDirector12/10/202013,872,320
Shah GauravPresident & CEO03/24/2020449,848
Shah GauravPresident & CEO03/24/202039,098
Patel KinnariChief Operating Officer03/18/20209,500
Shah GauravPresident & CEO02/25/2020125,595
Shah GauravPresident & CEO02/25/2020125,628
RTW INVESTMENTS, LPDirector12/10/20195,006,250
RTW INVESTMENTS, LPDirector04/16/20199,625,088
Shah GauravSee Remarks03/05/2019422,500
Shah GauravSee Remarks03/04/2019430,272
Shah GauravSee Remarks03/01/2019433,500
WONG RODERICKDirector12/28/20181,393,000
Patel KinnariChief Operating Officer12/20/201867,601
SOUTHWELL DAVID PDirector12/13/2018588,886
SOUTHWELL DAVID PDirector12/07/201873,402
SOUTHWELL DAVID PDirector12/06/2018800,056
Patel KinnariChief Operating Officer12/06/201885,011
WONG RODERICKDirector11/27/201815,000,001
Yalamanchi NaveenDirector08/01/201814,014
SOUTHWELL DAVID PPresident and CEO01/06/2017105,000
CARROLL J MARTINDirector05/13/201690,294
Devon Park Associates, L.P.10% Owner07/14/201542,799
Pitango Venture Capital Principals Fund IV, L.P.10% Owner02/23/20151,274,250
KARABELAS ARGERIS NDirector02/23/20153,622,992
CARE CAPITAL II LLC10% Owner02/23/20153,622,992
RHO VENTURES IV QP LP10% Owner02/23/20155,749,356
Kantesaria Devang10% Owner02/23/20154,884,996
DEVON PARK BIOVENTURES LP10% Owner02/23/20154,884,996
MedImmune Ventures, Inc.10% Owner02/23/20152,500,002
Load More Insider Transactions
FUNDS WITH A POSITION IN ROCKET PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,929,9100.00372%-0.00452%Other
MAVERICK CAPITAL LTD3,888,3121.97%-3.61%Growth At A Reasonable Price, Growth
GEODE CAPITAL MANAGEMENT, LLC1,502,5870.00374%3.11%Other
BAMCO INC /NY/990,5440.07%-5.89%Growth At A Reasonable Price
WCM INVESTMENT MANAGEMENT, LLC297,6580.02%0.56%Growth At A Reasonable Price
CANDRIAM S.C.A.165,0000.03%50%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.130,0000.00661%-7.14%Other
RENAISSANCE TECHNOLOGIES LLC62,6740.00291%ExitedOther
AQR CAPITAL MANAGEMENT LLC10,1180.00046%25.56%Other
CHANGE IN SHARES OUTSTANDING FOR ROCKET PHARMACEUTICALS INC
STOCK BUYBACKS FOR ROCKET PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
13.07%
1Q
12/31/2023
06/30/2023
16.11%
2Q
12/31/2023
03/31/2023
17.60%
3Q
12/31/2023
12/31/2022
22.34%
4Q
12/31/2023
09/30/2022
41.11%
5Q
12/31/2023
06/30/2022
42.71%
6Q
12/31/2023
03/31/2022
44.84%
7Q
12/31/2023
12/31/2021
44.97%
8Q
12/31/2023
09/30/2021
46.40%
9Q
12/31/2023
06/30/2021
48.17%
10Q
12/31/2023
03/31/2021
51.75%
11Q
12/31/2023
12/31/2020
65.99%
12Q
12/31/2023
09/30/2020
69.31%
13Q
12/31/2023
06/30/2020
69.40%
14Q
12/31/2023
03/31/2020
70.25%
15Q
12/31/2023
12/31/2019
82.39%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
13.07%
1Q
06/30/2023
16.11%
2Q
03/31/2023
17.60%
3Q
12/31/2022
22.34%
4Q
09/30/2022
41.11%
5Q
06/30/2022
42.71%
6Q
03/31/2022
44.84%
7Q
12/31/2021
44.97%
8Q
09/30/2021
46.40%
9Q
06/30/2021
48.17%
10Q
03/31/2021
51.75%
11Q
12/31/2020
65.99%
12Q
09/30/2020
69.31%
13Q
06/30/2020
69.40%
14Q
03/31/2020
70.25%
15Q
12/31/2019
82.39%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ROCKET PHARMACEUTICALS INC
LOADING...